Search hospitals > Ohio > Columbus
Aventiv Research, Inc.
Claim this profileColumbus, Ohio 43213
Global Leader in Diabetes
Global Leader in COVID-19
Conducts research for Type 2 Diabetes
Conducts research for Osteoarthritis
Conducts research for Coronavirus
225 reported clinical trials
5 medical researchers
Summary
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, COVID-19, Type 2 Diabetes, Osteoarthritis, Coronavirus and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 192 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.Area of expertise
1Diabetes
Global Leader2COVID-19
Global LeaderSARS-CoV-2
COVID-19 RNA-based
NAAT
Top PIs
Andrew W. PippasJohn B Amos Cancer Center7 years of reported clinical research
Studies Cancer
Studies Tumors
18 reported clinical trials
52 drugs studied
Samir Arora, MDAventiv Research Inc2 years of reported clinical research
Studies Osteoarthritis
Studies Neuralgia
15 reported clinical trials
18 drugs studied
Sridhar Guduri, MDAventiv Research Inc3 years of reported clinical research
Studies Allergy
Studies Peanut Allergy
14 reported clinical trials
20 drugs studied
Kenneth R BorenAventiv Research3 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
4 reported clinical trials
6 drugs studied
Clinical Trials running at Aventiv Research, Inc.
Obesity
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Diabetes
Fatty Liver Disease
Liver Disease
Chronic Kidney Disease
Cardiovascular Disease
Shingles
COVID-19
Orforglipron
for Type 2 Diabetes and Obesity
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits.
Recruiting2 awards Phase 3
Tirzepatide
for Obesity
The main purpose of this study is to evaluate the safety and efficacy of tirzepatide in adolescents that have obesity or overweight with at least one weight-related comorbidity. The study will last approximately 90 weeks and may include up to 25 visits.
Recruiting1 award Phase 33 criteria
Tirzepatide
for Obesity
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Aventiv Research, Inc.?
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, COVID-19, Type 2 Diabetes, Osteoarthritis, Coronavirus and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 192 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.